mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
0.37 |
0.003 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |